Sort   by:  
 Page size 
UnknownARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol.
Not available
S-EPMC10711912 | biostudies-literature
UnknownAdding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Not available
S-EPMC5961425 | biostudies-literature
UnknownRadiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
Not available
S-EPMC9173627 | biostudies-literature
UnknownAddition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Not available
S-EPMC6938598 | biostudies-literature
UnknownAbiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Not available
S-EPMC5533216 | biostudies-literature
UnknownAddition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Not available
S-EPMC4800035 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592 | biostudies-literature
UnknownThe influence of social media on recruitment to surgical trials.
Not available
S-EPMC7388470 | biostudies-literature
UnknownAbiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Not available
S-EPMC8811484 | biostudies-literature
UnknownAbiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Not available
S-EPMC7616864 | biostudies-literature
Sort   by:  
 Page size